Schizophrenia trials in Israel

In Israel 6 Also abroad 491

6 of 6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Completed
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Where
Ashkelon, Jerusalem, Petah Tikva, Ramat Gan
Age
55 years to 90 years
People
406 worldwide
Run by
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00
Phase 3Not yet taking people in Israel
Stratification and Treatment in Early Psychosis Study - ENHANCE
Where
Hod HaSharon, Petah Tikva, Ramat Gan
Age
16 years to 40 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT06778564 · EU 2025-521929-32-00
Phase 3Not yet taking people in Israel
Stratification and Treatment in Early Psychosis Study -ASSIST
Where
Hod HaSharon, Petah Tikva, Ramat Gan
Age
16 years to 50 years
People
250 worldwide
Run by
University of Oxford
See details and how to joinNCT07326124
Phase 2Taking people
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Where
Jerusalem
Age
18 years to 40 years
People
80
Run by
Amit Lotan
See details and how to joinNCT07759895
No phaseTaking people
A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
Where
Jerusalem
Age
18 years and over
People
200
Run by
Jerusalem Mental Health Center
See details and how to joinNCT07836348
Phase 1/2Taking people
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
Where
Beersheba, Ness Ziona, Ramat Gan, Tel Aviv
Age
18 years to 64 years
People
24 worldwide
Run by
Mapi Pharma Ltd.
See details and how to joinNCT07185815